Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

Share this content:

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

Sponsors and Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Immune Tolerance Network (ITN)

Principal Investigator
James Markmann, MD, PhD, Massachusetts General Hospital

ClinicalTrials.gov Identifier
NCT01318915

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters